Note

pubs.acs.org/joc

Stereoselective Synthesis of 3‑Methyleneisoindolin-1-ones via Base-
Catalyzed Intermolecular Reactions of Electron-Deﬁcient Alkynes
with N‑Hydroxyphthalimides
Xin Chen,
†
School of Basic Sciences, China Pharmaceutical University, Nanjing, 210009, P. R. China
‡
State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 210009, P. R. China
*S Supporting Information

and Qing-Fa Zhou*,†,‡

Fei-Fei Ge,

†

†

Tao Lu,*,†

ABSTRACT: Highly stereoselective intermolecular reactions of electron-deﬁcient alkynes with N-hydroxyphthalimides for
eﬃcient construction of N-unprotected 3-methyleneisoindolin-1-ones have been developed through base catalytic strategies. The
reaction of alkynoates with N-hydroxyphthalimides catalyzed by Bu3P in DMF at 150 °C gave the corresponding 3-
methyleneisoindolin-1-ones with a (Z)-conﬁguration, while the reaction of alkynoates with N-hydroxyphthalimides catalyzed by
K2CO3 in DMF at 60 °C gave the corresponding 3-methyleneisoindolin-1-ones with an (E)-conﬁguration, and (Z)-3-
methyleneisoindolin-1-ones were obtained when alkyne ketones reacted with N-hydroxyphthalimide.

I soindolinones are important scaﬀolds in organic chemistry

and medicinal chemistry due to their prevalence in
numerous synthetic and naturally occurring bioactive mole-
cules. In particular, 3-methyleneisoindolin-1-ones have been
recognized as core structures in natural compounds such as
enterocarpam II, the secophthalide−isoquinoline ene-lactam
fumaridine,1 magallanesine, an isoindolobenzazocine isolated
from the South-American plant Berberis darwinii.2 3-
Methyleneisoindolin-1-ones have shown a diverse range of
bioactivities, such as vasorelaxant property3 and local anesthetic
activity.4 In addition, 3-methyleneisoindolin-1-ones are also
important
the synthesis of other useful
alkaloids.5 Owing to their great importance, many methods
have been developed for the preparation of 3-methylene-
isoindolin-1-ones. These methods mainly involved the tradi-
tional condensation reaction of phthalimides with stabilized
phosphoranes,6 or addition of organometallic reagents,
followed by dehydration of the resulting 3-hydroxyphthalimi-
dines,7 the Horner condensation of 3-(diphenylphosphinoyl)-
isoindolin-1-ones with aldehydes,8 ortholithiation−anionic
cyclization of N-acyl-2-bromobenzamides,9 electrophilic cycli-
zations of 2-alkynylbenzamides,10 and recently developed
metal-catalyzed cascade reactions.11 However, most of
the
present procedures suﬀer from one or more drawbacks such as

intermediates for

the use of expensive metal reagents or poor stereoselectivity of
the products; therefore, more eﬃcient and simple protocols to
stereoselectively prepare 3-methyleneisoindolin-1-one would be
highly desirable.

Over the past 20 years, base-catalyzed annulation has grown
signiﬁcantly and represents one of the most powerful synthetic
methodologies for preparing various heterocyclic compounds.
Nonetheless, base catalytic, direct syntheses of 3-methylene-
isoindolin-1-one derivatives have seen considerably less
progress. We have recently developed a convenient phos-
phine-catalyzed [3 + 2] annulation of electron-deﬁcient alkynes
with N-hydroxyphthalimide (NHPI) for the synthesis of 3a-
hydroxyisoxazolo[3,2-a]isoindol-8(3aH)-ones (Scheme 1).12 In
the context of ongoing projects for the diversely functionalized
construction of isoindolin-1-ones, we wish to report the novel
process for stereoselective synthesis of 3-methyleneisoindolin-
1-ones (Scheme 1).
<para sub=“opt”>
We started our

investigation by examining the Bu3P-
catalyzed reaction of 2-hydroxyisoindoline-1,3-dione 1a and
ethyl propiolate 2a (Table 1). First, the reaction of 1a with 2a
</para>
Received:
Published: February 24, 2015

January 1, 2015

© 2015 American Chemical Society

3295

DOI: 10.1021/acs.joc.5b00002
J. Org. Chem. 2015, 80, 3295−3301

The Journal of Organic Chemistry

Note

Scheme 1. Phosphine-Catalyzed Reactions of 2-Hydroxyisoindoline-1,3-dione and Ethyl Propiolate

Table 1. Evaluation of Conditions for the Reaction of 1a with Ethyl Propiolate (2a)a

entry

catalyst (mol %)

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21d
22
23

Bu3P (10)
Bu3P (20)
Bu3P (50)
Bu3P (20)
Bu3P (20)
Bu3P (20)
Bu3P (20)
Bu3P (20)
Bu3P (20)
Bu3P (20)
Bu3P (20)
Bu3P (20)
Bu3P (20)
Bu3P (20)
Bu3P (20)
Ph3P (20)
Ph3P (20)
Ph2PEt (20)
Ph2PEt (20)
Et3N (20)
K2CO3 (20)
K2CO3 (20)

solvent
DMF
DMF
DMF
DMF
DMF
DMF
DMF
DMF
THF
CH2Cl2
CH2Cl2
CH3CN
CH3CN
toluene
toluene
DMF
DMF
DMF
DMF
DMF
DMF
DMF

temperature (°C)

time (h)

yield of 3 (%)b

yield of 4a (%)b

yield of 5a (%)b

r.t.c
r.t.
r.t.
0
−20
60
100
150
reﬂux
r.t.
reﬂux
r.t.
reﬂux
r.t.
reﬂux
100
150
100
150
60
60
100

48
24
2
48
6
6
2
2
48
48
48
48
12
48
12
18
16
18
14
4
4
6

48
0
0
40
97
0
0
0
0
18
38
31
0
30
0
0
0
0
0
0
0
0

42
69
76
36
0
74
80
0
0
28
35
49
65
19
51
40
0
51
0
0
73
0

0
11
6
14
0
17
11
95
0
5
11
10
13
trace
21
31
62
42
92
0
trace
74

aUnless noted otherwise, reaction of N-hydroxyphthalimide 1a (0.3 mmol), ethyl propiolate 2a (0.36 mmol) was performed in 1 mL of solvent
under N2. bIsolated yield based on 1a. cr.t. = room temperature. dThe Michael addition product was formed in 77% yield.
<para sub=“opt”>
in the presence of Bu3P (10 mol %) in DMF at room
temperature for 48 h aﬀorded the (E)-3-methyleneisoindolin-1-
one 4a in the yield of 42% accompanied by 3a-hydroxy-
isoxazolo[3,2-a]isoindol-8(3aH)-one derivative 3 in the yield of
48% (entry 1, Table 1). It was interesting to note that 3a-
hydroxyisoxazolo[3,2-a]isoindol-8(3aH)-one derivative 3 was
not found and the (E)-3-methyleneisoindolin-1-one 4a was
formed in good yield beside a little amount of (Z)-3-
methyleneisoindolin-1-one 5a when the loading of the catalyst
Bu3P was increased to 20 or 50 mol % (entries 2 and 3, Table
1). To improve the reaction selectivity, the temperature was
then evaluated. To our delight, an excelent yield of 5a was
obtained when the reaction was carried out at 150 °C (entry 8,
Table 1). The (E)-3-methyleneisoindolin-1-one 4a was formed
in good yield accompanied by a small quantity of its (Z)-isomer

5a when the reaction was disposed at 60 °C for 6 h or 100 °C
for 2 h (entries 6 and 7, Table 1). However, only 3a-
hydroxyisoxazolo[3,2-a]isoindol-8(3aH)-one derivative 3 was
given when the reaction was performed at −20 °C (entry 4,
Table 1). When shifting the solvent to THF, CH2Cl2, CH3CN,
or toluene, the reaction did not give the better results (entries
9−15, Table 1). Other nucleophilic phosphines was also tested,
and both Ph3P and Ph2PEt were proved to be useable catalysts
for 5a at 150 °C (entries17−20, Table 1). The base containing
nitrogen, such as Et3N, was also examined in the reaction; only
the Michael addition product was observed (entry 21, Table 1).
It is highlighted here that only (E)-3-methyleneisoindolin-1-
one 4a was given in 73% yield when the reaction was
performed in DMF at 60 °C for 4 h using inorganic base
K2CO3 as catalyst, and the sole product 5a was formed in 74%
</para>
3296

DOI: 10.1021/acs.joc.5b00002
J. Org. Chem. 2015, 80, 3295−3301

The Journal of Organic Chemistry

Note

Scheme 2. Transformation of Isoindolinone Derivatives at Diﬀerent Conditions
<para sub=“opt”>
yield when the reaction was performed in DMF at 100 °C for 6
h (entries 22 and 23, Table 1). Herein, we established the
optimal reaction conditions for the stereoselective synthesis of
N-unprotected 3-methyleneisoindolin-1-one derivatives via the
reaction conditions’ control.
</para>
<para sub="scope">
To understand these novel processes, 3a-hydroxyisoxazolo-
[3,2-a]isoindol-8(3aH)-one derivative 3 and (E)-3-methylene-
isoindolin-1-one 4a were treated under diﬀerent conditions
(Scheme 2). We found that compound 3a could be eﬀectively
transformed to (E)-3-methyleneisoindolin-1-one 4a in the
presence of a catalytic amount of both K2CO3 and Bu3P at 60
°C, while it was
fully transformed to (Z)-3-methylene-
isoindolin-1-one 5a at 150 °C in the presence of Bu3P or at
100 °C in the presence of K2CO3. We also found that (E)-3-
methyleneisoindolin-1-one 4a could be eﬀectively transformed
to (Z)-3-methyleneisoindolin-1-one 5a in the presence of a
catalytic amount of both K2CO3 and Bu3P at a higher
temperature, which shows a novel example that
the (E)-
conﬁguration of the carbon−carbon double bond could be
transformed to the (Z)-conﬁguration of the carbon−carbon
double bond. It is worth mentioning here that compound 3a
could also be transformed to (E)-3-methyleneisoindolin-1-one
4a and (Z)-3-methyleneisoindolin-1-one 5a in the absence of
catalyst, and compound 4a could also be transformed to its
isomer 5a. There is an obvious intramolecular hydrogen
bonding of the N−H group of 5a in its crystal structure, and
this could be the cause of the Z-stereoselectivity under higher
temperature.13
</para>
<para sub="scope">

With these results in hand, we ﬁrst investigated the scope of
alkynoates for the synthesis of (Z)-3-methyleneisoindolin-1-
ones (Table 2). As shown in Table 2, all terminal alkynoates
were proved to be applicable to this reaction and selectively
gave product (Z)-3-methyleneisoindolin-1-ones in good to
excellent yields under the optimized reaction conditions. The
alkynoates bearing both little alkyl units, namely, ethyl and
methyl, and a branched bulky alkyl group, such as t-butyl, could
give the products in 95, 99, and 99% yields, respectively
(entries1−3, Table 2). The nature of the substituent on the
benzene ring of the benzyl propiolate did impact the yields. For
example, for substrates with a halogen Cl or methoxy group
attached on the benzene ring, the yields of the corresponding
products were obtained in the yields of 98% and 86%,
respectively (entries 5 and 8, Table 2). Gratifyingly, furan-2-
ylmethyl propiolate also reacted smoothly with 2a to give the
desired (Z)-3-methyleneisoindolin-1-one 5i
in an excellent
</para>
Table 2. Bu3P-Catalyzed Synthesis of Z-3-
Methyleneisoindolin-1-onesa

entry
1
2
3
4
5
6
7
8
9
10

R

time (h)

product

yield (%)

Et
Me
t-Bu
PhCH2
4−Cl-C6H4CH2
4−Br-C6H4CH2
4-Me-C6H4CH2
4-MeO-C6H4CH2
2-furyl-CH2
Ph

2
2
2
2
2
2
4
6
2
6

5a
5b
5c
5d
5e
5f
5g
5h
5i
5j

95
99
99
99
98
94
90
86
99
71

aAll the reactions were carried out with 1a (0.3 mmol) and 2 (0.36
mmol) at 150 °C in 1.0 mL of DMF under N2, and isolated yields
were reported.
<para sub="scope">
yield (entry 9, Table 2). It is worthy to note that phenyl
propiolate could also proceed with 2a to provide the
corresponding (Z)-3-methyleneisoindolin-1-one 5j
in the
yield of 71%. However, only the 3a-hydroxyisoxazolo[3,2-
a]isoindol-8(3aH)-one products were formed, when β-sub-
stituted alkynoates were applied in the reaction.
</para>
<para sub="scope">
We then investigated the scope of alkynoates for

the
synthesis of (E)-3-methyleneisoindolin-1-ones in the presence
of K2CO3 (Table 3). As exempliﬁed in Table 3, a wide array of
alkynoates was suitable for the present strategy despite that
some examples need to be careful about
the reaction
temperature. For example,
the (E)-3-methyleneisoindolin-1-
ones were eﬀectively given at room temperature when methyl
propiolate or 4-bromophenyl propiolate was used in this
reaction; however, the (Z)-3-methyleneisoindolin-1-ones were
formed as major products at 60 °C for 2 h (entries 2 and 6,
Table 3). Notably, phenyl propiolate was also compatible with
the standard reaction conditions but in a decreased yield (entry
10, Table 3).
</para>
<para sub="scope">
To examine the scope of 2-hydroxyisoindoline-1,3-dione, 5,6-
dichloro-2-hydroxyisoindoline-1,3-dione (1b) was investigated.
As expected, the (Z)-ethyl 2-(5,6-dichloro-3-oxoisoindolin-1-
</para>
3297

DOI: 10.1021/acs.joc.5b00002
J. Org. Chem. 2015, 80, 3295−3301

The Journal of Organic Chemistry
Table 3. K2CO3-Catalyzed Synthesis of E-3-
Methyleneisoindolin-1-onesa

Scheme 4. Reactions of 2-Hydroxyisoindoline-1,3-dione (1a)
with Alkyne Ketones (8)

Note

entry

R

time (h)

product

yield (%)

1
2b
3
4
5
6b
7
8
9
10

Et
Me
t-Bu
PhCH2
4-Cl-C6H4CH2
4-Br-C6H4CH2
4-Me-C6H4CH2
4-MeO-C6H4CH2
2-furyl-CH2
Ph

4
12
4
4
4
12
6
6
4
6

4a
4b
4c
4d
4e
4f
4g
4h
4i
4j

73
66
62
60
62
60
60
57
63
29

aUnless noted otherwise, the reactions were carried out with 1a (0.3
mmol) and 2 (0.36 mmol) at 60 °C in 1.0 mL of DMF under N2, and
isolated yields were reported. bRoom temperature.
<para sub="scope">
ylidene)acetate (6) was formed in 90% yield when the reaction
was performed in DMF at 150 °C for 2 h in the presence of
Bu3P, while the (E)-ethyl 2-(5,6-dichloro-3-oxoisoindolin-1-
ylidene)acetate (7) was formed in 65% yield when K2CO3 was
used as catalyst in DMF at 60 °C for 2 h (Scheme 3).
</para>
Scheme 3. Reaction of 5,6-Dichloro-2-hydroxyisoindoline-
1,3-dione (1b) with Ethyl Propiolate (2a)
<para sub="scope">
Subsequently, promoted by the successful base-catalyzed
direct selective synthesis of 3-methyleneisoindolin-1-ones with
alkynoates, a range of alkyne ketones were also examined with
respect to 2-hydroxyisoindoline-1,3-dione 1a to synthesize 3-
methyleneisoindolin-1-one compounds. To our surprise, the
(Z) 3-methyleneisoindolin-1-ones were given when alkyne
ketones 8 and 1a were disposed in DMF at 60 °C in the
presence of K2CO3, while the reactions were very complicated
when the reactions were carried out in the presence of Bu3P
under diﬀerent
temperatures. Both aromatic and aliphatic
alkyne ketones could proceed smoothly to give (Z)-3-
methyleneisoindolin-1-ones in good yields (Scheme 4).
</para>
<para sub="scope">
Next, the free N−H group of 4a was attempted to protect
with 1-(bromomethyl)-4-nitrobenzene (10) (2.0 equiv) in the
presence NaH (2.0 equiv) in THF at 40 °C for 1 h. In the
reaction, N-benzyl-protected compound 11 was obtained in
88% yield (eq 1).
</para>

In conclusion, we have developed an eﬃcient and metal-free
protocol to synthesize (E)-3-methyleneisoindolin-1-ones and
(Z)-3-methyleneisoindolin-1-ones via base-catalyzed selective
reactions of electron-deﬁcient alkynes with N-hydroxy-
phthalimides. The present catalytic process provides a mild
and general access to the (E)-3-methyleneisoindolin-1-ones and
(Z)-3-methyleneisoindolin-1-ones, respectively. Especially, the
structures of these products are attractive for potential drug
discovery.

■ EXPERIMENTAL SECTION
<para sub=“exp”>
General Methods. All reactions were performed in anhydrous
solvents under a N2 atmosphere. THF, Et2O, and toluene were
distilled from K and Na metal, respectively. DMF, CH2Cl2, and
acetone were distilled from CaH2. CH3CN was distilled from P2O5. PE
refers to petroleum ether (boiling range: 60−90 °C). Melting points
were obtained on a melting point apparatus and are uncorrected. 1H
and 13C NMR spectra were recorded in DMSO-d6 using a 300 MHz
spectrometer: chemical shifts (δ) are given in parts per million,
coupling constants (J) in Hz. High-resolution mass spectra were
recorded in ESI mode on a QTOF MS spectrometer.

General Procedure for Reaction of Electron-Deﬁcient
Alkynes with N-Hydroxyphthalimide. To the solution of
electron-deﬁcient alkyne (0.36 mmol) and N-hydroxyphthalimide
(0.3 mmol) in dry DMF (1 mL) was added Ph3P (15.7 mg, 0.06
mmol). The resulting mixture was stirred at room temperature under a
nitrogen atmosphere for the required period of time. After completion
of the reaction as monitored by TLC, the reaction mixture was
quenched with CH2Cl2 (15 mL), which was washed with water and
brine successively, dried over MgSO4, ﬁltered, and concentrated in
vacuo. Puriﬁcation by ﬂash chromatography (SiO2; ethyl acetate/PE,
1:10−1:3) yielded the desired products.
(E)-Ethyl 2-(3-Oxoisoindolin-1-ylidene)acetate (4a). 47.54 mg,
73% isolated yield; white solid. mp: 95−97 °C. IR (KBr) 3744, 3722,
3651, 2360, 2345, 1770, 1750, 1734, 1717, 1700, 1683, 1657, 1562,
1504, 1458, 794 cm−1. 1H NMR (300 MHz, DMSO-d6): δ 10.34 (s,
1H), 8.11 (d, J = 7.3 Hz, 1H), 7.82 (d, J = 7.3 Hz, 1H), 7.72 (dt, J =
18.5, 7.2 Hz, 2H), 6.11 (s, 1H), 4.23 (q, J = 7.1 Hz, 2H), 1.28 (t, J =
7.1 Hz, 3H). 13C NMR (75 MHz, DMSO-d6): δ 167.9, 166.2, 146.6,
136.5, 133.1, 131.7, 128.7, 123.1, 122.0, 92.0, 59.9, 14.1. ESIHRMS:
Calcd for C12H12NO3: (M + H)+ 218.0812. Found: m/z 218.0815.
(E)-Methyl 2-(3-Oxoisoindolin-1-ylidene)acetate (4b). 40.20 mg,
66% isolated yield; white solid. mp: 197−199 °C; IR (KBr) 3167,
3113, 3086, 1744, 1715, 1643, 1694, 1632, 1607, 1454, 1373, 1302,
1273, 1157, 1115, 845, 773, 696 cm−1. 1H NMR (300 MHz, DMSO-
d6): δ 10.92 (s, 1H), 8.95 (d, J = 7.6 Hz, 1H), 7.83−7.66 (m, 3H),
5.80 (s, 1H), 3.72 (s, 3H). 13C NMR (75 MHz, DMSO-d6): δ 169.3,
</para>
3298

DOI: 10.1021/acs.joc.5b00002
J. Org. Chem. 2015, 80, 3295−3301

The Journal of Organic Chemistry
<para sub=“exp”>
167.8, 150.0, 135.5, 134.9, 133.7, 133.1, 129.5, 124.7, 99.7, 53.2.
ESIHRMS: Calcd for C11H9NNaO3: (M + Na)+ 226.0475. Found: m/
z 226.0479.
(E)-tert-Butyl 2-(3-Oxoisoindolin-1-ylidene)acetate (4c). 45.59 mg,
62% isolated yield; white solid. mp: 162−164 °C. IR (KBr) 3318,
2963, 2928, 1713, 1694, 1634, 1614, 1271, 1146, 1136, 1098, 1076,
856, 812, 696 cm−1. 1H NMR (300 MHz, DMSO-d6): δ 10.88 (s, 1H),
8.95 (d, J = 8.6 Hz, 1H), 7.79 (t, J = 6.8 Hz, 2H), 7.74−7.65 (m, 1H),
5.73 (s, 1H), 1.51 (s, 9H). 13C NMR (75 MHz, DMSO-d6): δ 167.4,
165.0, 147.2, 133.6, 132.9, 131.6, 131.2, 127.7, 122.7, 100.2, 79.9, 27.8.
ESIHRMS: Calcd for C14H16NO3: (M + H)+ 246.1125. Found: m/z
246.1129.
(E)-Benzyl 2-(3-Oxoisoindolin-1-ylidene)acetate (4d). 50.24 mg,
60% isolated yield; white solid. mp:185−187 °C. IR (KBr) 3181, 3080,
3071, 3030, 2994, 2843, 1721, 1701, 1643, 1634, 1468, 1454, 1155,
1140, 1117, 851, 741, 696 cm−1. 1H NMR (300 MHz, CDCl3): δ 9.41
(s, 1H), 9.09 (d, J = 7.7 Hz, 1H), 7.88 (d, J = 7.2 Hz, 1H), 7.66 (dt, J =
25.0, 7.4 Hz, 2H), 7.39 (dd, J = 14.6, 7.0 Hz, 5H), 5.97 (s, 1H), 5.28
(s, 2H). 13C NMR (75 MHz, CDCl3): δ 171.9, 168.3, 150.1, 138.5,
136.7, 136.0, 134.1, 133.7, 131.2, 131.1, 130.8, 130.8, 125.8, 102.5,
69.0. ESIHRMS: Calcd for C17H14NO3: (M + H)+ 280.0968. Found:
m/z 280.0972.
(E)-4-Chlorobenzyl 2-(3-Oxoisoindolin-1-ylidene)acetate (4e).
58.23 mg, 62% isolated yield; white solid. mp: 194−196 °C. IR
(KBr) 3204, 3192, 3115, 1753, 1715, 1651, 1454, 1265, 1223, 1153,
1107, 837, 808, 768 cm−1. 1H NMR (300 MHz, DMSO-d6): δ 10.98
(s, 1H), 8.94 (d, J = 7.5 Hz, 1H), 7.75 (ddd, J = 13.0, 11.4, 7.1 Hz,
3H), 7.53−7.35 (m, 4H), 5.83 (s, 1H), 5.21 (s, 2H). 13C NMR (75
MHz, DMSO-d6): δ 167.4, 165.2, 148.6, 135.2, 133.5, 133.0, 132.6,
131.8, 131.1, 129.8, 128.3, 127.6, 122.8, 97.4, 64.6. ESIHRMS: Calcd
for C17H12ClNNaO3: (M + Na)+ 336.0398. Found: m/z 336.0402.
(E)-4-Bromobenzyl 2-(3-Oxoisoindolin-1-ylidene)acetate (4f).
64.26 mg, 60% isolated yield; white solid. mp: 215−217 °C. IR
(KBr) 3306, 3275, 1722, 1682, 1667, 1651, 1470, 1416, 1294, 1280,
1200, 1125, 1063, 824, 770, 696 cm−1. 1H NMR (300 MHz, DMSO-
d6): δ 10.98 (s, 1H), 8.94 (d, J = 7.6 Hz, 1H), 7.81 (s, 1H), 7.72 (ddd,
J = 18.0, 10.5, 4.2 Hz, 2H), 7.57 (d, J = 8.3 Hz, 2H), 7.38 (d, J = 8.3
Hz, 2H), 5.83 (s, 1H), 5.19 (s, 2H). 13C NMR (75 MHz, DMSO-d6):
δ 167.4, 165.2, 148.7, 135.6, 134.2, 133.5, 133.0, 131.9, 131.3, 131.1,
130.1, 127.6, 122.8, 97.4, 64.6. ESIHRMS: Calcd for C17H13BrNO3:
(M + H)+ 358.0073. Found: m/z 358.0078.
(E)-4-Methylbenzyl 2-(3-Oxoisoindolin-1-ylidene)acetate (4g).
52.76 mg, 60% isolated yield; white solid. mp:166−168 °C. IR
(KBr) 3418, 3410, 3404, 1748, 1712, 1703, 1694, 1651, 1643, 1634,
1267, 1152, 1146, 1107, 847, 808 cm−1. 1H NMR (300 MHz, DMSO-
d6): δ 10.96 (s, 1H), 8.95 (d, J = 7.6 Hz, 1H), 7.92−7.55 (m, 3H),
7.30 (d, J = 7.7 Hz, 2H), 7.18 (d, J = 7.6 Hz, 2H), 5.81 (s, 1H), 5.16
(s, 2H), 2.29 (s, 3H). 13C NMR (75 MHz, DMSO-d6): δ 167.4, 165.3,
148.4, 137.3, 133.5, 133.1, 133.0, 131.8, 131.1, 128.9, 128.1, 127.6,
122.8, 97.7, 65.3, 20.6. ESIHRMS: Calcd for C18H16NO3: (M + H)+
294.1125. Found: m/z 294.1131.
(E)-4-Methoxybenzyl 2-(3-Oxoisoindolin-1-ylidene)acetate (4h).
52.86 mg, 57% isolated yield; white solid. mp:203−205 °C. IR (KBr)
3418, 3400, 2359, 2342, 1732, 1713, 1645, 1634, 1614, 1520, 1277,
1256, 1117, 843 cm−1. 1H NMR (300 MHz, DMSO-d6): δ 10.95 (s,
1H), 8.95 (d, J = 7.5 Hz, 1H), 7.8−7.64 (m, 3H), 7.36 (d, J = 8.6 Hz,
2H), 6.93 (d, J = 8.7 Hz, 2H), 5.79 (s, 1H), 5.14 (s, 2H), 3.74 (s, 3H).
13C NMR (75 MHz, DMSO-d6): δ 167.4, 165.3, 159.1, 148.3, 133.5,
133.0, 131.8, 131.1, 130.0, 128.0, 127.6, 122.8, 113.7, 97.8, 65.2, 55.0.
ESIHRMS: Calcd for C18H16NO4: (M + H)+ 310.1074. Found: m/z
310.1081.
(E)-Furan-2-ylmethyl 2-(3-Oxoisoindolin-1-ylidene)acetate (4i).
50.86 mg, 63% isolated yield; white solid. mp: 154−155 °C. IR
(KBr) 3192, 3183, 3136, 3112, 1728, 1705, 1636, 1613, 1267, 1157,
1142, 1105, 1076, 1001, 841, 752, 696 cm−1. 1H NMR (300 MHz,
CDCl3): δ 9.32 (s, 1H), 9.05 (d, J = 7.8 Hz, 1H), 7.86 (d, J = 7.2 Hz,
1H), 7.65 (dt, J = 24.5, 7.4 Hz, 2H), 7.45 (s, 1H), 6.47 (d, J = 2.9 Hz,
1H), 6.39 (d, J = 1.7 Hz, 1H), 5.90 (s, 1H), 5.20 (s, 2H). 13C NMR
(75 MHz, DMSO-d6): δ 168.0, 165.5, 149.9, 149.2, 144.2, 134.0,
</para>
Note
<para sub=“exp”>
133.6, 132.4, 131.7, 128.1, 123.4, 113.3, 113.2, 97.8, 57.9. ESIHRMS:
Calcd for C15H12NO4: (M + H)+ 270.0761. Found: m/z 270.0764.
(E)-Phenyl 2-(3-Oxoisoindolin-1-ylidene)acetate (4j). 23.06 mg,
29% isolated yield; white solid. mp: 196−198 °C. IR (KBr) 3161,
3088, 3071, 1713, 1643, 1634, 1611, 1591, 1493, 1271, 1204, 1136,
1096, 1072, 839, 775, 689 cm−1. 1H NMR (300 MHz, CDCl3): δ 9.10
(d, J = 6.7 Hz, 1H), 8.68 (s, 1H), 7.92 (dd, J = 5.5, 1.8 Hz, 1H), 7.73−
7.62 (m, 2H), 7.46 (t, J = 7.8 Hz, 2H), 7.31 (d, J = 7.4 Hz, 1H), 7.20
(d, J = 8.0 Hz, 2H), 6.09 (s, 1H). 13C NMR (75 MHz, CDCl3): δ
167.2, 153.2, 151.6, 136.5, 136.2, 135.6, 134.5, 133.5, 132.1, 131.5,
128.5, 126.0, 124.3, 101.2. ESIHRMS: Calcd for C16H12NO3: (M +
H)+ 266.0812. Found: m/z 266.0813.
(Z)-Ethyl 2-(3-Oxoisoindolin-1-ylidene)acetate (5a). 61.87 mg,
95% isolated yield; white solid. mp167−169 °C. IR (KBr) 3187, 1728,
1682, 1634, 1607, 1470, 1296, 1271, 1153, 1138, 1100, 1076, 854, 779,
698 cm−1. 1H NMR (300 MHz, DMSO-d6): δ 10.95 (s, 1H), 8.98 (d,
J = 7.6 Hz, 1H), 7.91−7.60 (m, 3H), 5.80 (s, 1H), 4.21 (q, J = 7.1 Hz,
2H), 1.28 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, DMSO-d6): δ
167.4, 165.5, 148.0, 133.6, 133.0, 131.7, 131.2, 127.6, 122.7, 98.2, 59.8,
14.1. ESIHRMS: Calcd for C12H12NO3: (M + H)+ 218.0812. Found:
m/z 218.0815.
(Z)-Methyl 2-(3-Oxoisoindolin-1-ylidene)acetate (5b). 60.31 mg,
99% isolated yield; white solid. mp: 122−124 °C. IR (KBr) 3404,
1732, 1667, 1651, 1645, 1634, 1614, 1441, 1283, 1209, 1128, 1097,
764, 692 cm−1. 1H NMR (300 MHz, CDCl3): δ 9.63 (s, 1H), 7.88 (d, J
= 4.2 Hz, 1H), 7.70 (d, J = 4.2 Hz, 1H), 7.64 (dd, J = 11, 4.2 Hz, 2H),
5.78 (s, 1H), 3.82 (s, 3H). 13C NMR (75 MHz, CDCl3): δ 168.0,
167.9, 147.5, 136.4, 132.8, 131.6, 129.6, 124.0, 121.01, 91.2, 51.7.
ESIHRMS: Calcd for C11H10NO3: (M + H)+ 204.0655. Found: m/z
204.0657.
(Z)-tert-Butyl 2-(3-Oxoisoindolin-1-ylidene)acetate (5c). 72.80
mg, Yield: 99% isolated yield; white solid. mp: 140−142 °C. IR
(KBr) 3188, 3175, 3078, 1720, 1699, 1707, 1682, 1643, 1368, 1279,
1258, 1153, 1138, 1115, 775, 694 cm−1. 1H NMR (300 MHz, CDCl3):
δ 9.65 (s, 1H), 7.88 (d, J = 4.4 Hz, 1H), 7.67 (d, J = 4.4 Hz, 1H), 7.61
(dt, J = 8.8, 4.2 Hz, 2H), 5.72 (s, 1H), 1.55 (s, 9H). 13C NMR (75
MHz, CDCl3): δ 168.0, 167.0, 146.6, 136.7, 132.6, 131.3, 129.6, 123.9,
120.8, 93.6, 81.3, 28.2. ESIHRMS: Calcd for C14H16NO3: (M + H)+
246.1125. Found: m/z 246.1128.
(Z)-Benzyl 2-(3-Oxoisoindolin-1-ylidene)acetate (5d). 82.89 mg,
99% isolated yield; white solid. mp: 146−148 °C. IR (KBr) 3322,
1742, 1692, 1668, 1645, 1424, 1298, 1277, 1211, 1198, 1177, 1161,
1128, 1065, 770, 692 cm−1. 1H NMR (300 MHz, CDCl3): δ 9.66 (s,
1H), 7.89 (d, J = 4.2 Hz, 1H), 7.75−7.57 (m, 3H), 7.40 (dt, J = 8.6, 4
Hz, 5H), 5.85 (s, 1H), 5.28 (s, 2H). 13C NMR (75 MHz, CDCl3): δ
168.0, 167.3, 147.9, 136.4, 135.7, 132.8, 131.6, 129.6, 128.6, 128.4,
128.3, 124.1, 121.0, 91.2, 66.4. ESIHRMS: Calcd for C17H14NO3: (M
+ H)+ 280.0968. Found: m/z 280.0975.
(Z)-4-Chlorobenzyl 2-(3-Oxoisoindolin-1-ylidene)acetate (5e).
92.04 mg, 98% isolated yield; white solid. mp 180−182 °C. IR
(KBr) 3325, 1740, 1688, 1667, 1422, 1296, 1275, 1196, 1171, 1126,
1094, 1063, 812, 768, 692 cm−1. 1H NMR (300 MHz, DMSO-d6): δ
10.43 (s, 1H), 8.09 (d, J = 7.2 Hz, 1H), 7.80 (d, J = 6.7 Hz, 1H), 7.72
(dd, J = 18.0, 7.3 Hz, 2H), 7.45 (s, 4H), 6.15 (s, 1H), 5.23 (s, 2H). 13C
NMR (75 MHz, DMSO-d6): δ 168.0, 165.8, 147.1, 136.4, 135.3,
133.1, 132.5, 131.7, 129.8, 128.7, 128.3, 123.1, 122.0, 91.5, 64.5.
ESIHRMS: Calcd for C17H13ClNO3: (M + H)+ 314.0578. Found: m/z
314.0585.
(Z)-4-Bromobenzyl 2-(3-Oxoisoindolin-1-ylidene)acetate (5f).
100.68 mg, 94% isolated yield; white solid. mp: 191−193 °C. IR
(KBr) 3327, 1738, 1688, 1682, 1667, 1422, 1294, 1275, 1196, 1171,
1126, 1063, 808, 768, 692 cm−1. 1H NMR (300 MHz, DMSO-d6): δ
10.44 (s, 1H), 8.10 (d, J = 7.3 Hz, 1H), 7.80 (d, J = 7.2 Hz, 1H), 7.70
(dt, J = 18.5, 7.2 Hz, 2H), 7.58 (d, J = 8.2 Hz, 2H), 7.39 (d, J = 8.3 Hz,
2H), 6.15 (s, 1H), 5.22 (s, 2H). 13C NMR (75 MHz, DMSO-d6): δ
168.0, 165.8, 147.1, 136.4, 135.7, 133.1, 131.7, 131.2, 130.1, 128.7,
123.1, 122.0, 121.1, 91.5, 64.5. ESIHRMS: Calcd for C17H12BrNO3:
(M + H)+ 358.0073. Found: m/z 358.0077.
(Z)-4-Methylbenzyl 2-(3-Oxoisoindolin-1-ylidene)acetate (5g).
79.14 mg, 90% isolated yield; white solid. mp: 154−156 °C. IR
</para>
3299

DOI: 10.1021/acs.joc.5b00002
J. Org. Chem. 2015, 80, 3295−3301

The Journal of Organic Chemistry
<para sub=“exp”>
(KBr) 3327, 1744, 1682, 1667, 1422, 1273, 1294, 1273, 1196, 1179,
1125, 1063, 814, 768, 691 cm−1. 1H NMR (300 MHz, DMSO-d6): δ
10.39 (s, 1H), 8.09 (d, J = 7.2 Hz, 1H), 7.80 (d, J = 7.2 Hz, 1H), 7.70
(dd, J = 10.7, 7.3 Hz, 2H), 7.31 (d, J = 7.8 Hz, 2H), 7.18 (d, J = 7.7
Hz, 2H), 6.13 (s, 1H), 5.19 (s, 2H), 2.29 (s, 3H). 13C NMR (75 MHz,
DMSO-d6): δ 167.9, 166.0, 146.9, 137.2, 136.4, 133.1, 133.1, 131.7,
128.8, 128.7, 128.1, 123.1, 122.0, 91.7, 65.2, 20.6. ESIHRMS: Calcd for
C18H16NO3: (M + H)+ 294.1125. Found: m/z 294.1131.
(Z)-4-Methoxybenzyl 2-(3-Oxoisoindolin-1-ylidene)acetate (5h).
79.75 mg, 86% isolated yield; white solid. mp: 173−175 °C. IR (KBr)
3339, 1742, 1682, 1667, 1660, 1651, 1645, 1634, 1514, 1470, 1120,
1173, 1060, 822, 168, 694 cm−1. 1H NMR (300 MHz, DMSO-d6): δ
10.39 (s, 1H), 8.09 (d, J = 7.5 Hz, 1H), 7.81 (d, J = 7.0 Hz, 1H), 7.70
(dd, J = 10.6, 7.4 Hz, 2H), 7.37 (d, J = 8.5 Hz, 2H), 6.94 (d, J = 8.5
Hz, 2H), 6.13 (s, 1H), 5.17 (s, 2H), 3.75 (s, 3H). 13C NMR (75 MHz,
DMSO-d6): δ 168.5, 166.6, 159.7, 147.4, 137.0, 133.6, 132.3, 130.6,
129.2, 128.6, 123.7, 122.5, 114.3, 92.3, 65.8, 55.6. ESIHRMS: Calcd for
C18H15NNaO4: (M + Na)+ 332.0893. Found: m/z 332.0896.
(Z)-Furan-2-ylmethyl 2-(3-Oxoisoindolin-1-ylidene)acetate (5i).
79.92 mg, 99% isolated yield; white solid. mp: 119−121 °C. IR
(KBr) 3426, 3333, 1746, 1732, 1688, 1665, 1645, 1422, 1198, 1177,
1126, 1062, 780, 687 cm−1. 1H NMR (300 MHz, DMSO-d6): δ 10.98
(s, 1H), 8.95 (d, J = 7.6 Hz, 1H), 7.84−7.66 (m, 4H), 6.58 (d, J = 3.0
Hz, 1H), 6.48 (s, 1H), 5.77 (s, 1H), 5.19(s, 2H). 13C NMR (75 MHz,
DMSO-d6): δ 168.5, 166.3, 149.9, 147.8, 144.1, 136.9, 133.6, 132.3,
129.2, 123.7, 122.6, 111.3, 111.2, 91.8, 57.8. ESIHRMS: Calcd for
C15H12NO4: (M + H)+ 270.0761. Found: m/z 270.0764.
(Z)-Phenyl 2-(3-Oxoisoindolin-1-ylidene)acetate (5j). 56.46 mg,
71% isolated yield; white solid. mp: 134−136 °C. IR (KBr) 3242,
1713, 1694, 1643, 1634, 1275, 1202, 1153, 1117, 1096, 1057, 692
cm−1. 1H NMR (300 MHz, CDCl3): δ 9.58 (s, 1H), 4.8 (d, J = 7.3 Hz,
1H), 7.78 (d, J = 4.4 Hz, 1H), 7.68 (dt, J = 12.1, 4.4 Hz, 2H), 7.44 (t, J
= 4.6 Hz, 2H), 7.28 (dd, J = 5.4, 3.1 Hz, 1H), 7.19 (d, J = 4.9 Hz, 2H),
6.02 (s, 1H). 13C NMR (75 MHz, CDCl3): δ 167.9, 166.1, 150.4,
149.2, 136.3, 133.0, 131.9, 129.4, 126.0, 124.2, 121.5, 121.2, 114.9,
90.4. ESIHRMS: Calcd for C16H12NO3: (M + H)+ 266.0812. Found:
m/z 266.0816.
(Z)-Ethyl 2-(5,6-Dichloro-3-oxoisoindolin-1-ylidene)acetate (6).
76.95 mg, 90% isolated yield; yellow solid. mp: 194−196 °C. IR
(KBr) 3390, 3381, 3242, 1737, 1732, 1694, 1682, 1651, 1645, 1634,
1614, 1557, 1537, 1505, 1271, 1067, 906, 854 cm−1. 1H NMR (300
MHz, DMSO-d6): δ 10.53 (s, 1H), 8.49 (s, 1H), 8.01 (s, 1H), 6.20 (s,
1H), 4.21 (q, J = 6.9 Hz, 2H), 1.26 (t, J = 7.0 Hz, 3H). 13C NMR (75
MHz, DMSO-d6): δ 167.9, 167.7, 146.4, 138.3, 137.9, 136.3, 130.8,
127.0, 126.3, 95.9, 62.0, 16.0. ESIHRMS: Calcd for C12H9Cl2N1NaO3:
(M + Na)+ 307.9852. Found: m/z 307.9857.
(E)-Ethyl 2-(5,6-Dichloro-3-oxoisoindolin-1-ylidene)acetate (7).
55.58 mg, 65% isolated yield; white solid. mp: 215−217 °C. IR
(KBr) 3200, 3109, 1743, 1732, 1713, 1694, 1643, 1634, 1607, 1393,
1280, 1145, 1105, 1036, 910, 850. 1H NMR (300 MHz, DMSO-d6): δ
11.18 (s, 1H), 9.10 (s, 1H), 7.95 (s, 1H), 5.77 (s, 1H), 4.18 (q, J = 7.0
Hz, 2H), 1.26 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, DMSO-d6): δ
167.3, 167.2, 147.9, 137.5, 136.6, 135.0, 133.3, 131.2, 126.5, 101.5,
62.1, 15.9. ESIHRMS: Calcd for C12H10Cl2N1O3: (M + H)+ 286.0032.
Found: m/z 286.0037.
(Z)-3-(2-Oxopropylidene) Isoindolin-1-one (9a). 33.67 mg, 60%
isolated yield; white solid. mp: 116−118 °C. IR (KBr) 3443, 3426,
3347, 3333, 1728, 1694, 1682, 1674, 1614, 1607, 1360, 1227, 1098,
760, 694 cm−1. 1H NMR (300 MHz, DMSO-d6): δ 10.55 (s, 1H), 8.01
(d, J = 7.5 Hz, 1H), 7.80 (m, 2H), 7.75−7.68 (m, 1H), 6.52 (s, 1H),
2.28 (s, 3H). 13C NMR (75 MHz, DMSO-d6): δ 200.2, 170.4, 146.4,
138.8, 136.1, 135.0, 133.8, 125.3, 124.7, 123.7, 101.4, 32.8. ESIHRMS:
Calcd for C11H10NO2: (M + H)+ 188.0707. Found: m/z 188.0706.
Isoindolin-1-one (9b). 37.36
mg, 50% isolated yield; yellow solid. mp: 165−167 °C. IR (KBr)
3333, 1720, 1651, 1599, 1300, 1227, 1018, 760, 710 cm−1. 1H NMR
(300 MHz, DMSO-d6): δ 10.89 (s, 1H), 8.34 (d, J = 7.5 Hz, 1H), 8.19
(d, J = 7.4 Hz, 2H), 7.81 (dd, J = 14.9, 7.4 Hz, 2H), 7.75−7.62 (m,
2H), 7.58 (t, J = 7.3 Hz, 2H), 7.39 (s, 1H). 13C NMR (75 MHz,
DMSO-d6): δ 191.7, 170.6, 149.4, 139.7, 139.0, 135.1, 134.9, 133.9,

(Z)-3-(2-Oxo-2-phenylethylidene)
</para>
Note
<para sub=“exp”>
(Z)-3-(2-(Naphthalen-2-yl)-2-oxoethylidene)

130.6, 130.3, 130.0, 125.2, 124.4, 97.5. ESIHRMS: Calcd for
C16H12NO2: (M + H)+ 250.0867. Found: m/z 250.0863.
Isoindolin-1-one
(9c). 45.76 mg, 51% isolated yield; white solid. mp: 211−213 °C. IR
(KBr) 3426, 3412, 3381, 3352, 1715, 1694, 1645, 1593, 810, 768 cm−1.
1H NMR (300 MHz, DMSO-d6): δ 10.95 (s, 1H), 8. 96 (s, 1H), 8.41
(d, J = 7.5 Hz, 1H), 8.18 (t, J = 8.6 Hz, 2H), 8.06 (dd, J = 15.2, 8.0 Hz,
2H), 7.86 (t, J = 8.4 Hz, 2H), 7.81−7.63 (m, 3H), 7.58 (s, 1H). 13C
NMR (75 MHz, DMSO-d6): δ 191.5, 170.7, 149.3, 139.1, 137.1,
136.9, 135.1, 134.1, 133.9, 131.8, 131.4, 130.5, 130.4, 130.3, 129.6,
128.8, 125.7, 125.3, 124.4, 97.7. ESIHRMS: Calcd for C20H14NO2: (M
+ H)+ 300.1019. Found: m/z 300.1026.
(E)-Ethyl 2-(2-(4-Nitrobenzyl)-3-oxoisoindolin-1-ylidene)acetate
(11). 98.76 mg, 88% isolated yield; white solid. mp: 138−140 °C.
IR (KBr) 3389, 3381, 1720, 1709, 1694, 1634, 1610, 1520, 1342, 1323,
1188, 1155, 1101, 829, 772, 708 cm−1. 1H NMR (300 MHz, DMSO-
d6): δ 8.94 (d, J = 7.4 Hz, 1H), 8.20 (d, J = 8.4 Hz, 2H), 7.92 (d, J =
7.2 Hz, 1H), 7.86−7.66 (m, 2H), 7.51 (d, J = 8.4 Hz, 2H), 5.78 (s,
1H), 5.22 (s, 2H), 4.17 (dd, J = 13.8, 6.9 Hz, 2H), 1.22 (t, J = 6.9 Hz,
3H). 13C NMR (75 MHz, DMSO-d6): δ 168.3, 167.0, 148.6, 145.9,
136.4, 135.5, 134.9, 133.7, 129.6, 129.3, 125.7, 125.1, 124.7, 101.3,
62.1, 43.6, 15.9. ESIHRMS: Calcd for C19H16N2NaO5: (M + H)+
375.0951. Found: m/z 375.0955.
</para>
■ ASSOCIATED CONTENT
*S Supporting Information
The ORTEP diagrams of 4a and 5a, 1H and 13C NMR spectra
of the products as well as the X-ray crystallographic data (CIF
ﬁles) of 4a and 5a. This material is available free of charge via
the Internet at http://pubs.acs.org.

■ AUTHOR INFORMATION
Corresponding Authors
*Fax: +86-025-86285179. Tel: +86-025-86185160. E-mail:
zhouqingfa@cpu.edu.cn (Q.-F.Z.).
*E-mail: lut163@163.com (T.L.).
Notes
The authors declare no competing ﬁnancial interest.

■ ACKNOWLEDGMENTS

This work was ﬁnancially supported by the National Natural
Science Foundation of China (Grant No. 21102179).

■ REFERENCES
(1) Blasko, G.; Gula, D. J.; Shamma, M. J. Nat. Prod. 1982, 45, 105−
122.
(2) Valencia, E.; Fajardo, V.; Freyer, A. J.; Shamma, M. Tetrahedron
Lett. 1985, 26, 993−996.
(3) (a) Kato, Y.; Takemoto, M.; Achiwa, K. Chem. Pharm. Bull. 1993,
41, 2003−2006. (b) Kato, Y.; Ebiike, H.; Achiwa, K.; Ashizawa, N.;
Kurihara, T.; Kobayashi, F. Chem. Pharm. Bull. 1990, 38, 2060−2062.
(4) Laboratori Baldacci, S. P. A. (Italy). Jpn. Patent 59046268, 1984.
(5) (a) Lu, W.-D.; Lin, C.-F.; Wang, C.-J.; Wang, S.-J.; Wu, M.-J.
Tetrahedron 2002, 58, 7315−7319. (b) Koradin, C.; Dohle, W.;
Rodriguez, A. L.; Schmid, B.; Knochel, P. Tetrahedron 2003, 59, 1571−
1587. (c) Kundu, N. G.; Khan, M. W. Tetrahedron Lett. 1997, 38,
6937−6940. (d) Yao, T.; Larock, R. C. J. Org. Chem. 2005, 70, 1432−
1437. (e) Wang, C.; Sun, C.; Weng, F.; Gao, M.; Liu, B.; Xu, B.
Tetrahedron Lett. 2011, 52, 2984−2989.
(6) Flitsch, W.; Peters, H. Tetrahedron Lett. 1969, 1161−1162.
(7) (a) Pigeon, P.; Decroix, B. Tetrahedron Lett. 1996, 37, 7707−
7710. (b) Daich, A.; Marchalin, S.; Pigeon, P.; Decroix, B. Tetrahedron
Lett. 1998, 39, 9187−9190. (c) Chihab-Eddine, A.; Daich, A.; Jilale, A.;
Decroix, B. Heterocycles 2002, 58, 449−456. (d) Kato, Y.; Ebiike, H.;
Achiwa, K.; Ashizawa, N.; Kurihara, T.; Kobayashi, F. Chem. Pharm.
Bull. 1990, 38, 2060−2062.

3300

DOI: 10.1021/acs.joc.5b00002
J. Org. Chem. 2015, 80, 3295−3301

Note

The Journal of Organic Chemistry

(8) (a) Couture, A.; Deniau, E.; Grandclaudon, P. Tetrahedron 1997,
53, 10313−10330. (b) Couture, A.; Deniau, E.; Grandclaudon, P.;
Hoarau, C. Tetrahedron 2000, 56, 1491−1499. (c) Couture, A.;
Deniau, E.; Grandclaudon, P.; Hoarau, C.; Rys, V. Tetrahedron Lett.
2002, 43, 2207−2210. (d) Couture, A.; Deniau, E.; Grandclaudon, P.;
Rybalko-Rosen, H.; Léonce, S.; Pfeiffer, B.; Renard, P. Bioorg. Med.
Chem. Lett. 2002, 12, 3557−3559. (e) Rys, V.; Couture, A.; Deniau, E.;
Grandclaudon, P. Tetrahedron 2003, 59, 6615−6619. (f) Moreau, A.;
Couture, A.; Deniau, E.; Grandclaudon, P. J. Org. Chem. 2004, 69,
4527−4530.
(9) Hendi, M. S.; Natalie, K. J., Jr.; Hendi, S. B.; Campbell, J. A.;
Greenwood, T. D.; Wolfe, J. F. Tetrahedron Lett. 1989, 30, 275−278.
(10) (a) Kundu, N. G.; Khan, M. W. Tetrahedron Lett. 1997, 38,
6937−6940. (b) Kundu, N. G.; Khan, M. W.; Mukhopadhyay, R.
Tetrahedron 1999, 55, 12361−12376. (c) Yao, T.; Larock, R. C. J. Org.
Chem. 2005, 70, 1432−1437.
(11) (a) Khan, M. W.; Kundu, N. G. Synlett 1997, 1435−1437.
(b) Sashida, H.; Kawamukai, A. Synthesis 1999, 1145−1148.
(c) Kundu, N. G.; Khan, M. W. Tetrahedron 2000, 56, 4777−4792.
(d) Koradin, C.; Dohle, W.; Rodriguez, A. L.; Schmid, B.; Knochel, P.
Tetrahedron 2003, 59, 1571−1587. (e) Uozumi, Y.; Kawasaki, N.;
Mori, E.; Mori, M.; Shibasaki, M. J. Am. Chem. Soc. 1989, 111, 3725−
3727. (f) Garcıa, A.; Rodrıguez, D.; Castedo, L.; Saa, C.; Domınguez,
D. Tetrahedron Lett. 2001, 42, 1903−1905. (g) Comins, D. L.; Joseph,
S. P.; Zhang, Y.-M. Tetrahedron Lett. 1996, 37, 793−796. (h) Wriggles-
worth, J. W.; Cox, B.; Lloyd-Jones, G. C.; Booker-Milburn, K. I. Org.
Lett. 2011, 13, 5326−5329. (i) Mancuso, R.; Ziccarelli, I.; Armentano,
D.; Marino, N.; Giofre, S. V.; Gabriele, B. J. Org. Chem. 2014, 79,
3506−3518. (j) Liu, X.; Hii, K. K. Eur. J. Org. Chem. 2010, 5181−5189.
(k) Zhou, B.; Hou, W.; Yang, Y.; Li, Y. Chem.Eur. J. 2013, 19,
4701−4706. (l) Patureau, F. W.; Besset, T.; Frohlich, R.; Glorius, F. C.
R. Chim. 2012, 15, 1081−1085.
(12) Zhou, Q.-F.; Chu, X.-P.; Ge, F.-F.; Wang, Y.; Lu, T. Adv. Synth.
Catal. 2013, 355, 2787−2792.
(13) CCDC 1032756 and CCDC 1032759 contain the supple-
mentary crystallographic data for compounds 4a and 5a, respectively.
These data can be obtained free of charge from The Cambridge
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/
cif.

3301

DOI: 10.1021/acs.joc.5b00002
J. Org. Chem. 2015, 80, 3295−3301

